erdafitinib (erda) or erda plus cetrelimab for patients with metastatic or locally advanced urot...
Published 2 years ago • 115 plays • Length 6:09Download video MP4
Download video MP3
Similar videos
-
2:20
erdafitinib /- cetrelimab in muc patients with fgfr alterations
-
3:42
norse: erdafitinib cetrelimab in muc with fgfr alterations
-
2:23
promising early results for cetrelimab plus erdafitinib reported for advanced uc | thomas powles
-
1:49
blc2001: erdafitinib for the treatment of metastatic urothelial carcinoma
-
2:31
an update on erdafitinib for metastatic/uresectable fgfr alteration urothelial carcinoma
-
2:34
norse: erdafitinib and cetrelimab in urothelial carcinoma
-
0:42
one of the biggest barriers to cancer treatment
-
4:43
erdafitinib for fgfr-mutated urothelial carcinoma
-
3:02
discussion on trial investigating erdafitinib in patients with urothelial cancer
-
2:21
dr. iyer on traes with erdafitinib in urothelial cancer
-
2:52
fgfri treatment-emergent aes in urothelial cancer
-
4:51
advances in radiotherapy for elderly patients with prostate cancer
-
0:56
are clinical trials safe?
-
7:31
investigational targetted therapeutic, entrectinib, shows promise against range of cancer types
-
1:43
eradic trial: preliminary results of mrd-guided ibrutinib plus venetoclax vs fcr
-
0:39
ecr 2021 | deliver precision diagnosis and interventions
-
2:04
esc tv at esc congress 2019 - icd use in hf (investigator)
-
1:17
exploratory analysis of the clarity study: ibrutinib plus venetoclax in patients with r/r cll